Down Syndrome Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

The global down syndrome market is expected to reach US$ 3,575.8 Million by 2028. The market is expected to experience the growth rate of 15.3% from 2021 to 2028. Down Syndrome also known as Trisomy 21, is a genetic condition that occurs when cell division takes place incorrectly. Such incorrect cell divisions give rise to an extra chromosome number 21 which further leads to chromosomal deformities like Down Syndrome. Down Syndrome affects the infected child mentally, slowing down the growth & developmental changes. In addition, Down Syndrome causes retardation of mental abilities, slow learning abilities, developmental delays, changes in language & behavior and the child lacks problem-solving abilities. The infected child is quite different from a normal child and shows certain developmental changes like small neck & head, short in height, flattened face, short in height, small neck & head, excessive flexibility, almond-shaped eyes pointing upwards, and short hands with a single crease in hand.
Down syndrome condition has become quite common; it affects 1 in 700 newborn children. Although women of any age can give birth to a Down Syndrome child, the chances of having an infected child rise in older women. About 5,300 babies with Down syndrome are born in the United States each year, and approximately 200,000 people in the USA have the condition. High prevalence in the number of Down Syndrome cases, awareness among the people, technological advancements in the fields of diagnosis & treatment, availability of specialized hospitals & clinics, access to novel therapies, and government fundings are the prominent reasons that boost the global Down Syndrome market. Down Syndrome disorder is a lifelong process and there are no specialized drugs or medications for the disorder. Additionally, an increase in government support for R&D activities focused on treatment therapies for Down syndrome contributes as drivers for the global Down Syndrome market growth.

Request for Sample Copy of this Research Report:
https://www.accurizemarketresearch.com/report/down-syndrome-market/sample-request

The Down Syndrome treatment market is bifurcated into disease type, test type, end-user, and distribution channel.
The Down Syndrome treatment market outlook – North America dominates the global Down Syndrome treatment market.
By region, the Down Syndrome treatment is segmented into North America, Europe, APAC, and MEA. Currently, North America is leading the global market.
Prominent players of the Down Syndrome market:
F. Hoffmann-La Roche Ltd, Kino Pharma Inc., ManRos Therapeutics, AC Immune SA, Aelis Pharma SAS, Alzheon Inc., Annovis Bio Inc., Illumina Inc., Eisai Co Ltd., Elixirgen Therapeutics LLC, Kino Pharma Inc., NeuroCircuit Therapeutics Inc., and NeuroNascent Inc.

Request For Customized report:
https://www.accurizemarketresearch.com/report/down-syndrome-market/ask-for-customization

Contact:
Rakesh K Singh
Head - Business Development
Patna Office (Asia):
K-129, PC Colony, Hanuman Nagar, Kankarbagh, Patna,
PIN - 800020
Tel: +1-339-368-6383/ +91-9665120699
Email: help@accurizemarketresearch.com
Web: https://www.accurizemarketresearch.com/
Accurize Market Research Blog:
https://www.accurizemarketresearch.com/blog-list

About Accurize Market Research-
Accurize Market Research (AMR) is a full-service market research and business-consulting company which provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.” Destined by the dedicated team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic across several industry verticals.
We at Accurize Market Research provide syndicated as well as customized reports across domains namely Consumer Goods, Food & Beverages, Manufacturing, Medical Devices, Mining Equipment, Automation, Manufacturing, Healthcare & Medical, and Defense & Aerospace, Semiconductor & Electronics, Construction, Information and Communication, Construction, Banking, Financial Services and Insurance (BFSI), and Energy among others. These industry vertical areas are further studied and analyzed across different geographies namely North America, Europe, Asia Pacific and Rest of the World (RoW). The countries across these major geographies are also covered under the scope of our study; such as the U.S., Mexico and Canada under North America; UK, Germany, Russia, Germany and France among others under Europe. Similarly, China, India, Taiwan, South Korea, Australia, Singapore and Japan among others are covered under Asia Pacific. Rest of the World (RoW) includes South & Central America, Middle East and Africa. Further, as per the scope countries across South & Central America, Middle East and Africa would also be studied separately under the scope of the report.
Available Report Format: Excel/PDF/PPT/Word

This release was published on openPR.